An Examination of the Effect of Rutin against Neurotoxicity Induced by Ciprofloxacin Antibiotic in Wistar Rats

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: English
View: 67

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_ARCHRAZI-77-2_040

تاریخ نمایه سازی: 6 دی 1402

Abstract:

Rutin is a citrus flavonoid that exists in different types of food, such as fruits, tea, as well as vegetables, and is considered a natural antioxidant. This study aimed to investigate the therapeutic role of Rutin in oxidative stress-induced in Wistar rats exposed to Ciprofloxacin (CPX). The study included ۳۶ healthy adult Wistar rats, which were randomly divided into six groups (n=۶). The control group (C) received normal drinking water for ۲۰ days. The first treatment group (T۱) received Rutin at a dose of ۵۰ mg/kg of b.w for ۲۰ days. The second treatment group (T۲) received CPX antibiotic at a dose of ۱۴ mg/kg of b.w for ۲۰ days. The third treatment group (T۳) received Rutin at a dose of ۵۰ mg/kg of b.w for ۲۰ days, and afterward, they received CPX antibiotic at a dose of ۱۴ mg/kg of b.w for ۲۰ days. The fourth treatment group (T۴) received CPX antibiotic at a dose of ۱۴ mg/kg of b.w for ۲۰ days, and then, they received Rutin at a dose of ۵۰ mg/kg of b.w for ۲۰ days. The fifth treatment group (T۵) received CPX antibiotic at a dose of ۱۴ mg/ kg of b.w and Rutin at a dose of ۵۰ mg/ kg of b.w together for ۲۰ days. All the treatments were administrated by oral gavage. Analysis of the recorded data showed a significant increase (P<۰.۰۵) in the concentration of Methylenedioxyamphetamine (MDA) in the T۲ group, compared to the other groups. The MDA level significantly (P<۰.۰۵) increased in the T۳ group (۲.۲۹±۰.۰۴), compared to the C (۱.۷۱±۰.۰۱), T۱ (۱.۵۴±۰.۰۴), T۴ (۱.۱۸±۰.۰۲), and T۵ (۱.۲۹±۰.۰۳) groups. However, there were no significant differences (P<۰.۰۵) between the C (۱.۷۱±۰.۰۱) and T۱ (۱.۵۴±۰.۰۴) groups, as well as the T۴ (۱.۱۸±۰.۰۲) and T۵ (۱.۲۹±۰.۰۳) groups with regards to the MDA. The results clarified a significant increase (P<۰.۰۵) in the antioxidant activity, Glutathione (GSH), Superoxide dismutase (SOD), and Catalase (CAT) contents in the T۱ group, determined at ۵.۹۱±۰.۲۶, ۵.۷۸±۰.۰۲, and ۱.۹۸±۰.۰۵, respectively, compared to the other groups. The lowest antioxidant activity, GSH, SOD, and CAT contents were recorded in the T۲ group, in comparison with the other groups (P<۰.۰۵). The findings revealed that the level of SOD, GSH, and CAT in the T۴ and T۵ groups significantly (P<۰.۰۵) increased, compared to the T۲ and T۳ groups. Histological examination of the slides obtained from the brain demonstrated that in the T۲ group, some histopathological changes were observed, compared to the C, T۱, T۴, and T۵ groups. These changes were as follows: ۱) damaged and clear blood vessel congestion with the deposition of fibrous networks, ۲) brain edema, ۳) multiple necrotic foci, ۴) accumulation of neutrophils, and ۵) simple histopathological changes in the brain of animals in the T۲ group, compared to the other groups. It is, therefore, concluded that Rutin supplementation at a dose of ۵۰ mg/kg b.w can be the most appropriate dose in protecting brain tissue against tissue damages caused by CPX.

Authors

A. J Al-Naely

Department of Biology, College of Education, University of Al-Qadisiyah, Al Diwaniyah, Iraq

H. A Al-Hamadawi

Department of Biology, College of Education, University of Al-Qadisiyah, Al Diwaniyah, Iraq

J. K Alumeri

Department of Biology, College of Education, University of Al-Qadisiyah, Al Diwaniyah, Iraq

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Rawi SM, Alshibly NM, El-Nasr FS. Neurotoxic effect of ciprofloxacin ...
  • Dhivya D, Vijayakumar B. A focus on quinolones and its ...
  • Bradley JS, Jackson MA, Diseases CoI. The use of systemic ...
  • Ooie T, Terasaki T, Suzuki H, Sugiyama Y. Quantitative brain ...
  • Ahmed AI, van der Heijden FM, van den Berkmortel H, ...
  • Arora R, Gupta D, Chawla R, Sagar R, Sharma A, ...
  • Guardia T, Rotelli AE, Juarez AO, Pelzer LE. Anti-inflammatory properties ...
  • Ganeshpurkar A, Saluja AK. The pharmacological potential of rutin. Saudi ...
  • Mostafa NM. Comparative analysis of rutin content in some Egyptian ...
  • Khan MM, Ahmad A, Ishrat T, Khuwaja G, Srivastawa P, ...
  • Food, Administration D. Guidance for industry and reviewers. Estimating the ...
  • Aebi H. Catalase. Methods of enzymatic analysis: Elsevier; ۱۹۷۴. p. ...
  • Hakuna L, Doughan B, Escobedo JO, Strongin RM. A simple ...
  • Momen Beitollahi J, Mansourian A, Momen Heravi F, Amanlou M, ...
  • Guidet B, Shah S. The level of malondialdehyde after activation ...
  • Banchroft J, Stevens A, Turner D. Theory and practice of ...
  • Montgomery DC. Design and analysis of experiments: John wiley & ...
  • Elbe H, Dogan Z, Taslidere E, Cetin A, Turkoz Y. ...
  • Páez PL, Becerra MC, Albesa I. Comparison of macromolecular oxidation ...
  • Afolabi OK, Oyewo EB. Effects of ciprofloxacin and levofloxacin administration ...
  • Qin P, Liu R. Oxidative stress response of two fluoroquinolones ...
  • Ilgin S, Can OD, Atli O, Ucel UI, Sener E, ...
  • Erkan H, Aliseydi B, Keskin E, Abdullah E, Ali GM, ...
  • Shenbagam M, Nalini N. Dose response effect of rutin a ...
  • Guo R, Wei P, Liu W. Combined antioxidant effects of ...
  • Kaiserová H, Šimůnek T, van der Vijgh WJ, Bast A, ...
  • Al-Enazi MM. Protective effects of combined therapy of Rutin with ...
  • Nijveldt RJ, Van Nood E, Van Hoorn DE, Boelens PG, ...
  • Ahmed MM, Zaki NI. Assessment the ameliorative effect of pomegranate ...
  • El-Naga RN, Ahmed HI, Abd Al Haleem EN. Effects of ...
  • Ng F, Berk M, Dean O, Bush AI. Oxidative stress ...
  • Shahzad N, Ahmad J, Khan W, Al-Ghamdi SS, Ain MR, ...
  • Enogieru AB, Haylett W, Hiss DC, Bardien S, Ekpo OE. ...
  • Almutairi MM, Alanazi WA, Alshammari MA, Alotaibi MR, Alhoshani AR, ...
  • Yuceli S, Yazici GN, Mammadov R, Suleyman H, Kaya M, ...
  • Lee W, Ku S-K, Bae J-S. Barrier protective effects of ...
  • نمایش کامل مراجع